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The standard Salmonella mutagenicity (Ames) tester strains are missing 15–119 genes due to the
extended D(gal-bio-uvrB) mutations that render the
strains excision-repair deﬁcient (DuvrB). We constructed strains of Salmonella that are homologous
to tester strains TA98 and TA100 except that in
place of the uvrB deletion, they contain singlegene defects in either uvrB, moaA, moeA, or both
uvrB and moeA. We then tested the following
mutagens in these strains: 2-acetylaminoﬂuorene,
Glu-P-1, 4-aminobiphenyl, benzo[a]pyrene, MX,
1-nitropyrene, 6-hydroxylaminopurine (HAP), and
2-amino-6-hydroxylaminopurine (AHAP). We conﬁrmed in Salmonella a previous ﬁnding in Escherichia coli that the enhanced mutagenicity of the
purine analogues HAP and AHAP is not due to
the deletion of the uvrB gene but due to the deletion of moeA and/or moaA, which are involved
in molybdenum cofactor biosynthesis. The sponta-

neous mutant frequency and induced mutagenic
potency of mutagens due to the extended DuvrB
mutation are due largely to the deletion of uvrB
and to some extent of moeA/moaA at the frameshift hisD3052 allele of TA98 but involve other
genes in addition to uvrB and moeA/moaA at the
base-substitution hisG46 allele of TA100. The
extended DuvrB mutation does not prevent the
detection of mutagens that would have been
detected in a strain containing a single uvrB
defect. Because of the deletion of moeA/moaA,
the extended uvrB deletion generally enhanced
spontaneous and induced mutagenicity, especially
at the base-substitution allele. This enhanced sensitivity may underlay the severe health effects in
humans who have mutations in molybdenum cofactor biosynthesis genes. Environ. Mol. Mutagen.
48:694–705, 2007. Published 2007 Wiley-Liss, Inc.
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INTRODUCTION
The Salmonella (Ames) mutagenicity assay, introduced
more than 35 years ago [Ames, 1971], is still the most
widely used assay for evaluating drugs, industrial chemicals, and environmental samples for mutagenic activity
[Mortelmans and Zeiger, 2000]. The S. enterica Typhimurium strains used in the assay contain various histidine alleles, and mutagenesis is measured by reversion to histidine independence [Maron and Ames, 1983]. In addition,
the tester strains also contain various mutations and
genetic factors that enhance the sensitivity of the bacteria
to mutagens.
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The ﬁrst of these mutations to be added was a DuvrB
allele, which eliminated nucleotide excision repair and
conferred enhanced sensitivity to many mutagens [Ames,
1971]. Five different DuvrB alleles, formally called chl
(bio uvrB gal), were isolated independently for inclusion
in the main tester strains [Busch et al., 1986; Popkin
et al., 1989]. Because of the methods used to introduce
these and other mutations, as well as the pKM101 plasmid, strains containing the same histidine allele are not
isogenic [Popkin et al., 1989].
Each DuvrB allele was isolated as a mutation conferring anaerobic resistance to chlorate, which is a consequence of the loss of one or more genes involved in molybdenum cofactor biosynthesis [Shanmugam et al., 1992;
Rajagopalan, 1996]. Three of the ﬁve operons required
for molybdenum cofactor biosynthesis (mod, moa, and
moe) are located near the uvrB gene in Escherichia coli
and Salmonella, providing a convenient means by which
to eliminate nucleotide excision repair in these bacteria
[Shanmugan et al., 1992; Rajagopalan, 1996].
When the DuvrB alleles were introduced into what
would eventually become the Ames tester strains, all that
was known was that each mutation resulted in a single
deletion through at least the galactose operon, biotin operon, uvrB gene, and chlorate-resistance genes, making
the Ames tester strains double auxotrophs for both histidine and biotin [Ames, 1971]. For the next 30 years,
nothing more was known about the size of these deletions
or other genes that were missing until we used genomic
hybridization to show that the Ames strains are missing
15-119 genes due to the DuvrB mutations [Porwollik
et al., 2001]. In particular, strain TA98 is missing 119
genes (125 kb of DNA or 2.6% of the genome), and
TA100 is missing 47 genes (50 kb of DNA or 1.9% of
the genome). Among the questions raised by this ﬁnding
is whether the enhanced sensitivity of the Ames strains to
various mutagens is due to the elimination of the nucleotide excision repair system alone or to the deletion of
other genes.
Although similarly derived DuvrB mutations in E. coli
have not been fully characterized with regard to the extent
of the deletions, studies by one of us (RMS) revealed that
such E. coli D(uvrB-bio) strains were hypersensitive (both
in terms of killing and mutagenesis) to the base analogues
6-hydroxylaminopurine (HAP) and 2-amino-6-hydroxylaminopurine (AHAP) [Pavlov et al., 1996; Kozmin et al.,
2000]. In contrast, strains containing a point mutation in
either uvrA or uvrB were not hypersensitive, indicating
that the hypersensitivity does not result from the lack of
nucleotide excision repair [Pavlov et al., 1996; Kozmin
et al., 2000]. Instead, hypersensitivity was shown to result
directly from the loss of the genes for molybdenum cofactor biosynthesis [Kozmin et al., 2000].
To explore this observation in Salmonella and to
expand the analysis to mutagens other than base ana-
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logues, we constructed homologues of the two main
Ames tester strains, the frameshift strain TA98 and the
base-substitution strain TA100, but carrying single-gene
mutations in either uvrB, moeA, or moaA, or in both uvrB
and moeA, instead of their respective D(gal-bio-uvrB)
mutations. In addition to HAP and AHAP, we also tested
the nitroarene 1-nitropyrene (1-NP), the heterocyclic
amine Glu-P-1, the aromatic amines 2-acetylaminoﬂuorene (2-AAF) and 4-aminobiphenyl (4-AB), the polycyclic
aromatic hydrocarbon benzo[a]pyrene (BaP), and the
chlorinated organic 3-chloro-4-(dichloromethyl)-5-hydroxy2(5H)-furanone (MX), which is the primary mutagen in
chlorinated drinking water. Four are direct-acting mutagens
(HAP, AHAP, 1-NP, and MX), and four require metabolic
activation (Glu-P-1, 2-AAF, 4-AB, and B[a]P).
The results were analyzed to assess the inﬂuence of the
various mutations on spontaneous mutant frequency and
the mutagenic potencies of the various mutagens relative
to the corresponding TA98 and TA100 tester strains. We
assessed whether the missing genes in the Ames DuvrB
strains actually enhanced the mutagenic sensitivity of
these strains relative to those containing a mutation in
only the uvrB gene. Finally, we identiﬁed some human
homologues among the 119 genes deleted by DuvrB in
TA98 and discuss the possible role that mutations in these
genes may play in human disease.
MATERIALS AND METHODS
Chemicals
Glu-P-1 was obtained from Toronto Research Chemicals (North York,
ON, CA), and HAP was obtained from MP Biomedicals (Solon, OH). 1NP, 2-AAF, 4-AB, and BaP were purchased from Sigma (St. Louis,
MO). MX was a gift from R. Franzén, Tampere University of Technology, Tampere, Finland. AHAP was a gift from I. Kuchuk, Indiana University. All of the mutagens were dissolved in dimethyl sulfoxide
(DMSO, Burdick and Jackson, Muskegon, MI).

Strains
Strain TA100 [hisG46 chl-1005 (bio uvrB gal) rfa-1001 pKM1011
Fels-11 Fels-21 Gifsy-11 Gifsy-21] and TA98 [hisD3053 chl-1008 (bio
uvrB gal) rfa-1004 pKM1011 Fels-11 Fels-21 Gifsy-11 Gifsy-21] were
obtained from B.N. Ames, Oakland Children’s Hospital, Oakland, CA.
All of the other strains had the same genotype as either TA98 or TA100
except that DuvrB mutation (bio uvrB gal) was replaced with a singlegene mutation in either the uvrB, moeA, or moaA genes or in both the
uvrB and moeA genes (Table I).

Strain Construction
All new tester strains were constructed starting from S. typhimurium
LT2 strains HisG46 and HisD3052 provided by Dr. T. Cebula (US
FDA). These are the original parents of the TA100 and TA98 tester
strains and carry the hisG46 and hisD3052 markers, respectively [Ames,
1971; Popkin et al., 1989]. Phage P22 HT 12/4 int used for transductions
of Salmonella strains was obtained from Dr. R. Maurer (Case Western
Reserve University). P22 transductions were performed as described in
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TABLE I. Strains Constructed for Use in This Study
TA98 homologues
Strain
SN13504
SN13506
SN15944
SN15948

a

TA100 homologues

b

Relevant
defect

Strain

Relevant
defect

moeA
moaA
uvrB
uvrB moeA

SN13497
SN13499
SN15939
SN15942

moeA
moaA
uvrB
uvrB moeA

a

The genotype of frameshift strain TA98 is hisD3053 chl-1008 (bio
uvrB gal) rfa-1004 pKM1011 Fels-11 Fels-21 Gifsy-11 Gifsy-21. The
TA98 homologues have the noted single-gene mutations instead of the
chl-1008 (bio uvrB gal) mutation, which is the DuvrB mutation.
b
The genotype of base-substitution strain TA100 is hisG46 chl-1005 (bio
uvrB gal) rfa-1001 pKM1011 Fels-11 Fels-21 Gifsy-11 Gifsy-21. The
TA100 homologues have the noted single mutations instead of the chl1005 (bio uvrB gal) mutation, which is the DuvrB mutation.
Sternberg and Maurer [1991]. Transductions in E. coli and in rough
(galE) strains of Salmonella were performed using a laboratory stock of
P1virA. Phage C21, used for selecting deep-rough (waa, previously
called rfa) variants, was purchased from the NCCB (Netherlands Culture
Collection of Bacteria, Utrecht, The Netherlands). Salmonella strains
TT4799 (bio-101::Tn10, galE) and TT22971 (metA22 metE551 trpD2
ilv-452 leu pro hsdLT6 hsdSA29 hsdB strA120 [pKD46]) were obtained
from Dr. J. Roth (University of California at Davis). Salmonella strains
RM2721 (galE496, metE55, rpsL120, xyl-404, H1-b, H2-e,n,x, ﬂiB,
ilv452, hdsL6(r2m1), hsdSA29(r2m1), Fels-22) and RM2725 (as
RM2721, but mutL::Tn10) were obtained from Dr. R. Maurer (Case
Western Reserve University). Salmonella strain TAC22 (trpB223,
pKM101) was obtained from Dr. T. Cebula (US FDA). E. coli moeA or
moaA donor strains NR12383 (moeA121::mini-Tn10cam) [Kozmin et al.,
2000] and NR13488 (moaA130::mini-Tn10cam) [unpublished data] were
derived in the author’s (RMS) laboratory.
The DuvrB 501::kan allele was created in Salmonella strain TT22972
using the PCR-based gene replacement method of Datsenko and Wanner
[2000]. The PCR primers used contained 50-nt extensions complementary to the left or right end of the gene to be deleted as well as a 20-nt
priming 30 end complementary to the kanamycin-resistance (Kanr) of
plasmid pKD13 [Datsenko and Wanner, 2000]. The genomic base-pair
coordinates of the left and right endpoints of the deletion were 864,663
and 866,297, respectively, according to the published sequence of the
Salmonella typhimurium genome [McClelland et al., 2001, GenBank record NC_003197] and correspond to deletion of residues 76-622 of the
UvrB protein. Selection was for kanamycin resistance. The presence of
the deletion in new isolates was conﬁrmed by PCR followed by testing
for sensitivity to UV light. The new uvrB allele, designated DuvrB
501::kan, was then transferred by transduction using phage P22 into
HisG46 and HisD3052 yielding SN15820 (hisG46 DuvrB) and SN15821
(hisD3052 DuvrB). The latter two strains were then used as donors to
introduce this DuvrB allele into the new tester strains, as described later.
First, HisG46 and HisD3052 were converted to their bio derivatives by
P22-mediated transduction using Salmonella donor strain TT4799 (bio101::Tn10, galE) using selection for tetracycline resistance. These strains
were then converted to corresponding bio1 galE496 derivatives by P22mediated transduction using as RM2721 as donor, selecting for growth on
minimal medium lacking biotin. The new galE derivatives were named
SN13394 (hisG46 galE496) and SN13396 (hisD3052 galE486). The galE
strains displayed the expected rough phenotype as evidenced by their
acquired sensitivity to bacteriophage P1 when grown in LB medium and
their retained sensitivity to P22 when grown in the presence of galactose.
The galE derivatives were used to introduce the moaA and moeA alleles
present in E. coli strains NR13488 and NR12383, respectively, by P1
transduction. First, to overcome the restriction and homeology barriers

between E. coli and Salmonella, the moeA and moaA alleles were transferred by P1 transduction into RM2725, in which the cross-species transductions proceeded with good efﬁciency [Rayssiguier et al., 1989]. The
presence of the moa or moe allele was conﬁrmed by sensitivity to the
base analog HAP resulting from their lack of molybdenum cofactor
[Kozmin et al., 2000; Kozmin and Schaaper, 2007]. To minimize retention
of linked E. coli sequences, the moaA and moeA alleles were cycled
through RM2721 or RM2725 for an additional four or ﬁve times by
repeated, sequential P1 transductions.
P1-mediated transfer of the moaA or moeA alleles into SN13394
(hisG46) or SN13396 (hisD3052) then yielded the following strains:
SN13465 (hisG46 moaA), SN13470 (hisG46 moeA), SN13466 (hisD3052
moaA), and SN13474 (hisD3052 moeA). These strains and their parents
were then made DuvrB by P22-mediated transduction using SN15820
and SN15821 as donors. Selection was for kanamycin resistance; the
new transductants were conﬁrmed by their UV sensitivity. In this manner
we created the following strains: SN15916 (hisG46 DuvrB), SN15919
(hisG46 moaA DuvrB), SN15920 (hisG46 moeA DuvrB), SN15922
(hisD3052 DuvrB), SN15924 (hisD3052 moaA DuvrB), and SN15926
(hisD3052 moeA DuvrB).
Deep-rough (waa, formerly called rfa) variants of the various strains
were selected on the basis of their resistance to phage C21. LB plates
were spread with 0.1 ml (108) C21 phage. After the plates had dried
thoroughly, 0.1 ml of an overnight LB culture of a bacterial strain was
spread on top of the phage. Plates were incubated overnight at 378C. Typically, the next day these plates contained 2–50 phage-resistant colonies.
Several of these were re-streaked on a C21-containing LB plate, and wellgrowing colonies were puriﬁed one more time on an LB plate without
C21. Deep-rough mutants among them were then identiﬁed based on their
sensitivity to crystal violet. The crystal violet test was performed by adding 10 ml of a crystal violet solution (10 mg/ml) to a small ﬁlter disk
placed in the center of an LB plate on which the strain of interest had
been plated in a soft-agar layer. Under these conditions, waa mutants
show a clear zone of killing or nongrowth, whereas waa1 strains are not
signiﬁcantly inhibited. In this manner we obtained the following strains:
SN13439 (hisG46 waa-117), SN13419 (hisG46 moaA waa-101), SN13454
(hisG46 moeA waa-125), SN15928 (hisG46 DuvrB waa-141), SN15930
(hisG46 moaA DuvrB waa-145), SN15931 (hisG46 moeA DuvrB waa149), SN13441 (hisD3052 waa-121), SN13421 (hisD3052 moaA waa109), SN13458 (hisD3052 moeA waa-133), SN15933 (hisD3052 DuvrB
waa-153), SN15935 (hisD3052 moaA DuvrB waa-157), and SN15937
(hisD3052 moeA DuvrB waa-161).
Finally, plasmid pKM101 was added to these constructs by mating
with plasmid pKM101 donor strain TAC22 and selecting conjugants on
minimal-medium plates containing histidine and ampicillin (100 mg/ml).
In this manner, we obtained the following strains: SN13495 (hisG46
waa-117 pKM101), SN13499 (hisG46 moaA waa-101 pKM101),
SN13497 (hisG46 moeA waa-125 pKM101), SN15939 (hisG46 DuvrB
waa-141 pKM101), SN15941 (hisG46 moaA DuvrB waa-145 pKM101),
SN15942 (hisG46 moeA DuvrB waa-149 pKM101), SN13502 (hisD3052
waa-121 pKM101), SN13506 (hisD3052 moaA waa-109 pKM101),
SN13504 (hisD3052 moeA waa-133 pKM101), SN15944 (hisD3052
DuvrB waa-153 pKM101), SN15946 (hisD3052 moaA DuvrB waa-157
pKM101), and SN15948 (hisD3052 moeA DuvrB waa-161 pKM101).

Mutagenesis
The strains were grown overnight (16 h) in Oxoid nutrient broth No. 2
and used with or without S9 mix (Aroclor-induced rat liver S9 from
Moltox, Boone, NC) in the standard plate-incorporation assay [Maron
and Ames, 1983]. Each compound was tested at least twice (and sometimes up to four times) per strain at 2 plates per dose. Three plates were
used for all DMSO controls. Positive controls were omitted in a formal
sense because most of the mutagens used are positive controls or are
well-established mutagens in TA98 and TA100. All experimental runs
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TABLE II. Spontaneous Mutant Yields (Mutant Frequencies) and P-Values Comparing Strains for 1S9
(Top and Above Diagonal) and 2S9 (Left and Below Diagonal)
Strain (mutation)

Frameshift
TA98 [D(gal-bio-uvrB)]
SN13504 (moeA)
SN13506 (moaA)
SN15944 (uvrB)
SN15948-1 (uvrB moeA)

Base substitution
TA100 [D(gal-bio-uvrB)]
SN13497 (moeA)
SN13499 (moaA)
SN15939 (uvrB)
SN15948-2 (uvrB moeA)

Mean 6 SE

a

25
16
16
24
18

6
6
6
6
6

2
3
3
3
4

Mean 6 SEa
103
14
33
87
76

6
6
6
6
6

2
3
3
4
4

TA98 (DuvrB)

SN13504 (moeA)

SN13506 (moaA)

SN15944 (uvrB)

SN15941 (uvrB moeA)

36 6 2

26 6 3

30 6 3

34 6 4

36 6 5

––––
0.005
0.006
0.62
0.06

0.003
––––
0.99
0.07
0.67

0.07
0.19
––––
0.07
0.68

0.61
0.12
0.47
––––
0.20

0.97
0.07
0.30
0.73
––––

TA100 (DuvrB)

SN13497 (moeA)

SN13499 (moaA)

SN15939 (uvrB)

SN15942 (uvrB moeA)

111 6 3

18 6 3

32 6 3

83 6 5

94 6 6

––––
<0.0001
<0.0001
0.0004
<0.0001

<0.0001
––––
<0.0001
<0.0001
<0.0001

<0.0001
0.0005
––––
<0.0001
<0.0001

<0.0001
<0.0001
<0.0001
––––
0.05

0.007
<0.0001
<0.0001
0.14
––––

a
Mean revertants/plate 6 standard error from mixed model: means to the right correspond to 1S9; means below to 2S9. These spontaneous mutant
yields are the same as the spontaneous mutant frequencies, where the units would be revertants/108 survivors. For comparison, the spontaneous mutant frequencies (average of 1S9 and 2S9) of the homologous strains having only his and rfa mutations and the pKM101 plasmid are 19 for the
TA98 homologue (UTH8413) and 33 for the TA100 homologue (TA92) [DeMarini, 2000].

used a parental strain (TA98 and TA100) and their respective homologues. Plates were incubated for 3 days, and revertants (rev) were
counted on an AccuCount 1000 automated colony counter (BioLogics,
Manassas, VA). 1-NP, MX, HAP, and AHAP were tested without S9
mix, whereas BaP, 4-AB, 2-AAF, and Glu-P-1 were tested with S9 mix.

Statistical Analysis
We conducted a separate analysis for each mutagen. Each analysis
used data from all 10 strains and multiple experimental runs (8 each for
AHAP, 4-AB, and MX; 9 each for 2-AAF and Glu-P-1; and 10 for the
remaining compounds) conducted on different dates. Each experimental
run involved several, though possibly different, dose levels and only a
subset of the strains. Each compound-strain-run-dose combination used 2
or 3 replicate plates. We modeled the counts from each plate using generalized linear mixed models assuming a Poisson error distribution with
the identity link function. We modeled the expected response for each
plate as a linear function of dose with a separate intercept and slope for
each strain (after omitting data from high dose levels where the response
leveled off). We considered run, any interactions involving run, and replicate plates as possible sources of extra-Poisson variation.
The strain-speciﬁc slope parameters in each analysis represent the
strain-speciﬁc potencies of the respective compound (rev/lg). Our modeling approach appropriately integrates all the individual experimental runs
with possibly different numbers of dose levels and different subsets of
strains to provide a single potency estimate for each strain for each compound. The variance reported for the potency estimates takes account of
all sources of extra-Poisson variation mentioned earlier. We used SAS
software (SAS Institute, Cary, NC), in particular the GLIMMIX macro, to
ﬁt these models <http://support.sas.com/ctx/samples/index.jsp?sid5536>.
The spontaneous mutant yields (rev/plate) for all of the strains were
calculated from all the control (DMSO) plates from all of the experiments, using a Poisson mixed model. We modeled the expected response
for each plate using a factorial analysis-of-variance approach: main
effects for strain (10 levels) and S9 (2 levels) as well as interaction
terms. As before, we considered run, any interactions involving run, and
replicate plates as possible sources of extra-Poisson variation.

Identification of Human Homologues of Deleted
Salmonella Genes
We identiﬁed the human genes that are homologous to the 119 genes
deleted in TA98 by comparing the amino acid sequences of the resulting
proteins available in databases maintained by the National Center for
Biotechnology Information at the National Institutes of Health. Thus, the
GeneID number for each of the 119 genes missing from TA98 was
obtained from the S. typhimurium LT2 complete genome protein table at
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db5genome&cmd5Retrieve
&dopt5Protein1Table&list_uids5202. The protein reference sequences
keyed to the GeneID numbers for the identiﬁed genes were then submitted
to protein-protein BLAST (http://www.ncbi.nlm.nih.gov/BLAST/beta/
Blast.cgi?PAGE5Proteins&PROGRAM5blastp&BLAST_PROGRAMS5
blastp&PAGE_TYPE5BlastSearch&SHOW_DEFAULTS5on). The protein sequence was used to search the swissprot database (see above URL)
for human homologues. Human homologues with e-values <10225 were
examined in Online Mendelian Inheritance in Man (OMIM) for human
disorders associated with nonfunctional genes (http://www.ncbi.nlm.nih.
gov/entrez/query.fcgi?db5OMIM).

RESULTS
Spontaneous Mutant Yields (Mutant Frequencies)
The raw data are available online at the following URL (http://
www.interscience.wiley.com/jpages/0893-6692/suppmat).
Table II shows the estimated mean of the spontaneous
mutant yields (rev/plate), which are also mutant frequencies (rev/108 treated cells or 108 survivors), for all of the
strains. P-values compare the spontaneous mutant yields
among strains of one allele either with or without the
addition of S9 mix. Strain-to-strain differences are more
common at the base substitution allele than at the frameshift allele, regardless of the presence or absence of S9.
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Fig. 1. Average (6 SE) spontaneous mutation frequencies of TA98 and TA100 with and without S9 as estimated by a Poisson mixed model. *, signiﬁcantly different from Ames homologues at P < 0.05.

Moreover, the addition of S9 increased signiﬁcantly (P <
0.05) the spontaneous mutant frequencies of TA98 and all
of its homologues as well as those of TA100 and one of
its homologues, SN15942 (uvrB moeA) (statistics not presented).
In the absence or presence of S9, the spontaneous mutant frequency of TA98 was not signiﬁcantly different
from that of a strain with the single uvrB mutation or the
strain with the combined single uvrB and moeA mutations
(Table II). This observation suggests that the absence of
nucleotide excision repair alone accounts for essentially
all of the spontaneous mutant frequency of TA98 due to
the extended DuvrB mutation, whereas absence of the
remaining genes may contribute little to the spontaneous
mutant frequency of this strain. Single defects in either
moeA or moaA produced signiﬁcantly lowered spontaneous mutant frequencies relative to TA98 in the absence of
S9, as did moeA in the presence of S9.
In contrast, the spontaneous mutant frequency of the
base-substitution strain TA100 differed signiﬁcantly from
all of its homologues containing single-gene defects (Table II). Thus, a single defect in moeA, moaA, or uvrB, or
in uvrB and moeA together, signiﬁcantly lowered the
spontaneous mutant frequency relative to TA100. These
results indicate that at the base-substitution allele, the
spontaneous mutant frequency observed in TA100 is due
not only to the deletion of uvrB but also to the absence of
molybdenum cofactor biosynthesis, as well as possibly

other genes in the extended DuvrB mutation, which
involves the deletion of 47 genes.
Considering all possible strain comparisons at the
base-substitution allele, all comparisons with one exception (uvrB vs. uvrB moeA in the presence of S9) are signiﬁcantly different from each other. This pattern clearly
indicates the important contribution that the deletion of
each gene (uvrB, moeA, or moaA) plays in the spontaneous mutant frequency at the base-substitution allele. In
contrast, at the frameshift allele, strains carrying mutations in only the molybdenum cofactor biosynthesis
genes have signiﬁcantly lower spontaneous frequencies:
TA98 vs. moeA or moaA (-S9) and TA98 vs. moeA
(1S9). Therefore, as long as the uvrB mutation is present, the spontaneous mutant frequency is not signiﬁcantly different from TA98.
A tendency exists, however, for the spontaneous mutant
frequency to be lower in the double mutant (uvrB moeA)
than in either the single uvrB or D(gal-bio-uvrB) strain
for both the frameshift and the base-substitution alleles
when S9 is not used. With the addition of S9, the spontaneous mutant frequency of the double mutant increased
and became identical (frameshift allele) or similar (basesubstitution allele) to the D(gal-bio-uvrB) strain (Fig. 1).
Thus, moeA defects tend, overall, to lower the spontaneous mutant frequency, even when combined with a uvrB
defect, and this tendency is reversed somewhat with the
addition of S9, especially at the frameshift allele. As a

Environmental and Molecular Mutagenesis. DOI 10.1002/em
Enhanced Mutagenesis of Salmonella Tester Strains

699

Fig. 2. Average mutagenic potencies (rev/lg) of all mutagens tested in
all strains as estimated by a Poisson mixed model. Error bars show the
upper 95% conﬁdence limit for each mean. P-values refer to compari-

sons of an Ames strain to each of its homologues; *, not signiﬁcantly
different from zero (i.e., not mutagenic) at P < 0.05. The vertical scales
differ among the panels for illustrative purposes. (Continued on next page)

result, molybdenum cofactor biosynthesis genes may play
a role in determining mutagenic potency even in TA98
and/or may be a factor in the increased spontaneous mutant frequency seen with the use of S9.

Mutagenic Potencies of Base Analogues
The potencies of HAP and AHAP in TA98 and its
homologues tended to vary considerably about the mean
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Fig. 2. (Continued)

(Fig. 2). Nonetheless, the base analogues HAP and AHAP
were generally not mutagenic in strains containing the frameshift allele.
At the base-substitution allele, HAP and AHAP produced results similar to those obtained by Kozmin et al.
[2000] in E. coli. Both compounds were mutagenic only
when a molybdenum cofactor biosynthesis gene (moeA or
moaA) was mutated, and both compounds produced their

highest mutagenic potencies in a strain containing a single
defect in only the moaA gene (Fig. 2). Neither compound
was mutagenic in a strain containing a mutation in only
the uvrB gene (Fig. 2). These results indicate that the absence of the 47 genes in TA100 reduces the mutagenic
potency of the base analogues compared to their potency
in a strain mutant in only the molybdenum operons. Thus,
as in E. coli, these base analogues are mutagenic in a
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TABLE III. Relative Inﬂuence of Single-Gene Defects on Mutagenic Potencies Compared to D(gal-bio-uvrB)
TA98 [D(gal-bio-uvrB)]
Mutagen
HAP
AHAP
1-NP
MX
BaP
4-AB
2-AAF
Glu-P-1

moeA or moaA
a

NM
NM
;
;
5
5
;
;

TA100 [D(gal-bio-uvrB)]

uvrB

uvrB, moeA

moeA or moaA

uvrB

uvrB, moeA

NM
NM
;
5
5
5
;
;

NM
NM
:
:
5
5
5
5

:
:
;
;
;
;
;
;

;
;
;
;
;
;
;
;

;
;
;
;
;
5
;
:

a

NM, not mutagenic.

DuvrB strain of Salmonella not because of the absence of
nucleotide repair but because of the absence of molybdenum cofactor biosynthesis.
Mutagenic Potencies of Nonbase Analogues
The mutagenic potencies of the nonbase analogues varied widely across frameshift strains (Fig. 2), but most
nonbase analogues were mutagenic in every strain. 4-AB
and BaP were exceptions: both were nonmutagenic (P >
0.67) in strains moeA (SN13504) and moaA (SN13506),
and 4-AB was nonmutagenic (P 5 0.06) in strain uvrB
(SN15944). The latter is the only instance in which a nonbase analog was statistically not mutagenic in a strain
containing a deletion in the uvrB gene and was most
likely due to the high variability about the mean. Even
with this high variability, the P-value approached signiﬁcance; therefore, it is likely that 4-AB is weakly mutagenic in SN15944.
At the frameshift allele, 2-AAF, 1-NP, and Glu-P-1
were signiﬁcantly less mutagenic in the uvrB strain
(SN15944) relative to TA98 (Fig. 2). Thus, the deletion of
genes in addition to those involved in nucleotide excision
repair accounted for the potencies of these compounds in
TA98. In contrast, 4-AB, BaP, and MX had mutagenic
potencies that were not signiﬁcantly different in the uvrB
strain (SN15944) relative to TA98, suggesting that the deletion of uvrB alone may account for the potencies of these
compounds in TA98. 2-AAF, 1-NP, Glu-P-1, and MX
were less mutagenic in strains containing a defect in moeA
(SN13504) or moaA (SN13506) relative to TA98. In contrast, 4-AB and BaP had mutagenic potencies in moeA or
moaA strains that were not signiﬁcantly different from
those in TA98. However, this may be due to the presence
of high variability about the mean because the trend is for
much lower potencies in moeA or moaA strains compared
to uvrB strains even for these compounds.
At the frameshift allele, nonbase analogues tended to
exhibit higher mutagenic potencies in the double mutant
(uvrB moeA) compared with TA98. However, this was
signiﬁcant only in the direct-acting (those requiring no

metabolic activation) compounds 1-NP and MX. The indirect acting (those requiring metabolic activation with S9)
compounds 2-AAF, 4-AB, Glu-P-1, and BaP, did not
have signiﬁcantly different potencies in the double mutant
than in TA98. This suggests that the deletion of one or
more of the 119 genes of the D(gal-bio-uvrB) in TA98
may actually interfere with the ability of these compounds
to exhibit their full mutagenic potency at the frameshift
allele and that the interference is lessened with the addition of S9.
The mutagenic potencies of the nonbase analogues varied widely across base-substitution strains (Fig. 2), but
only Glu-P-1 and MX were mutagenic in every strain. 2AAF, 4-AB and BaP were nonmutagenic (P > 0.07) in
the strains moeA (SN13504) and moaA (SN13506), and 1NP was not mutagenic in strain moaA (P 5 0.75).
At the base-substitution allele, 2-AAF, 1-NP, BaP, and
MX were signiﬁcantly less mutagenic in the single uvrB
mutant strain (SN15939) than in TA100, suggesting that
the deletion of other genes in conjunction with uvrB
accounts for the potency of these compounds in TA100.
Also at the base-substitution allele, the mutagenic potencies of all of the nonbase analogues were less in strains
with single defects in moeA (SN13497) or moaA
(SN13499) compared with TA100. This observation indicates that the absence of the molybdenum cofactor synthesis genes alone does not account for the mutagenic
potencies of the nonbase analogues in TA100. The mutagenic potencies of 2-AAF, 1-NP, BaP, and MX were
also less in a strain having mutations in both moeA and
uvrB (SN15942) relative to TA100. Thus, the deletion of
additional genes beyond those involved in nucleotide
excision repair and molybdenum cofactor synthesis
accounts for the mutagenic potencies of these compounds in TA100. In contrast, the mutagenic potency of
4-AB in strain SN15942 was not signiﬁcantly different
than in TA100, and Glu-P-1 was more mutagenic in
strain SN15942 than in TA100. The relative inﬂuence of
the single-gene defects on the mutagenic potencies of all
of the mutagens compared to the D(gal-bio-uvrB) strains
is shown in Table III.

Environmental and Molecular Mutagenesis. DOI 10.1002/em
702

Swartz et al.

Human Homologues of Deleted Salmonella Genes
At least 17 of the 119 genes deleted in TA98 are homologous to human genes (Table IV). Among these are
genes involved in molybdenum cofactor biosynthesis,
whose deletion clearly increased some induced mutagenicity in Salmonella. As discussed later, deﬁciency in this
activity also is associated with severe human disease [Lee
et al., 2002].
DISCUSSION
Spontaneous Mutation
At the base-substitution allele, none of the single-gene
mutation strains had spontaneous mutant frequencies as
high as TA100. Thus, deletion of additional genes plays a
role in the spontaneous mutant frequency of TA100. In contrast, the uvrB frameshift strain had a spontaneous mutant
frequency that was not signiﬁcantly different from that of
TA98. Thus, deletion of uvrB alone appears to be sufﬁcient
to account for the effect of the D(gal-bio-uvrB) mutation at
the frameshift allele. The situation is likely more complex,
with the deletion of various genes (119 in TA98) having a
net inﬂuence on the spontaneous mutant frequency.
As discussed below under mechanistic considerations,
the absence of some of the genes deleted by D(gal-biouvrB) in TA98 and TA100 may reduce DNA repair and
replication ﬁdelity as well as detoxiﬁcation of DNA-reactive agents. Consequently, the loss of such mechanisms
would likely increase the spontaneous mutant frequency
as well as induced mutagenic sensitivity. The differential
effects of the deletions on spontaneous mutant frequencies
at the frameshift vs. base-substitution alleles are unclear,
especially considering the many other deleted genes
whose effects we have not yet explored systematically.
Nonetheless, our results clearly show that genes other
than uvrB inﬂuence the spontaneous mutant frequency of
the DuvrB strains of the Ames Salmonella tester set.
Base Analogues
Elimination of genes in the molybdenum cofactor biosynthesis pathway is both necessary and sufﬁcient to
account for the mutagenicity of the base analogs HAP
and AHAP in TA100. These compounds are not mutagenic in a strain containing a single uvrB defect. This
result conﬁrms previous observations in E. coli [Kozmin
et al., 2000]. Thus, the mutagenic activity of these compounds in TA100 is not due to the deletion of uvrB but to
the deletion of moeA or moaA in the D(gal-bio-uvrB)
mutation of TA100.
Of the two molybdenum cofactor biosynthesis pathway
genes examined, the absence of moaA appears to play the
major role in enhancing mutagenic potency. Absence of
moaA resulted in a signiﬁcant increase in potency over

that of TA100, especially for AHAP, whereas the absence
of moeA resulted in potency values that were either not
different or, in fact, signiﬁcantly lower than that of TA100.
The moa operon codes for the synthesis of molybdopterin,
a key protein in molybdenum cofactors of all organisms,
whereas genes in the moe operon appear to be involved in
the transfer of sulfur groups to molybdenum or other components of the cofactor complex [Rajagopalan, 1996]. The
molybdoenzymes play a general role in protecting against
N-hydroxylated base analogs and related compounds; thus,
their deletion removes this protection, enhancing mutagenesis by these agents.
Nonbase Analogues
As noted by Rosenkranz and Mermelstein [1983], Nhydroxyl compounds (hydroxylamines) are the active intermediates for the mutagenicity of both aromatic nitro compounds (by reduction) and aromatic amines (by oxidation).
Our results with compounds in these chemical classes,
which are HAP, AHAP, 1-NP, Glu-P-1, 2-AAF, and 4-AB,
support this idea. In contrast, the mutagenic potencies of
the other compounds were much less in strains having single moeA or moaA defects than in TA98 or TA100. In general, the mutagenic potencies of these compounds were
similar in each D(gal-bio-uvrB) strain and its homologue
with a single uvrB defect. Potencies were increased further
by the additional mutation in a molybdenum cofactor biosynthesis gene. Thus, the elimination of the nucleotide
excision repair pathway appears to play a signiﬁcant role in
the enhanced mutagenic potency of most compounds in
strains containing the D(gal-bio-uvrB) mutation.
Mutagenic potencies of the compounds other than HAP
and AHAP in strains containing mutations in both uvrB
and moeA were higher than in strains with single defects
in either uvrB or moeA alone. In TA98 homologues, the
absence of both uvrB and moeA often resulted in potency
enhancement relative to the D(gal-bio-uvrB) homologue
(TA98), indicating that there is some interference with
mutagenic enhancement caused by some of the other
genes deleted by the D(gal-bio-uvrB) mutation. This interference does not, however, diminish the ability of TA98
to identify mutagens. Conversely, although the same potency enhancement by uvrB and moeA occurs in TA100
homologues, the potency levels do not reach those
attained in TA100 itself, indicating that the absence of
additional genes is required to produce the mutagenic potency observed in TA100.
Mechanistic Considerations
It may seem counter-intuitive that the deletion of many
genes would enhance the mutagenic sensitivity of an organism. How might missing genes enhance mutagenic
sensitivity beyond the deletion of uvrB? Ames [1971]
selected strains that were the most sensitive to a variety
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5.30 E2163

E-value
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459771
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moeB
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459782
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459773
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459823

moeA
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459832

459755
459769
459798
459815

459835

Salmonella NP
accession number

moaA

galE
hutH
rhlE
ybiT

Salmonella gene
symbol

Genes deleted from both TA98 and TA100; otherwise genes are missing from only TA98.

a

577

Score (bits)

STM0858

Salmonella
gene identiﬁer

Glycine C-acetyltransferase (GCAT)
2-@Methylbutyryl-CoA dehydrogenase
(SBCAD)
Molybdenum cofactor biosynthesis
protein 1B (MOCS1B)
Molybdenum cofactor synthesis 1
(MOCS1)
Similar to Ornithine aminotransferase,
mitochondrial precursor
ATP-binding cassette, sub-family A,
member 8 (ABCA8)
CDK5 regulatory subunit associated
protein 1(CDK5RAP1)
ATP-binding cassette, sub-family A,
member 12 (ABCA12)
Threonine aspartase 1

Electron-transferring-ﬂavoprotein
dehydrogenase
UDP-glucose 4-epimerase
Histidine ammonia-lyase
ATP-dependent RNA helicase (DDX3X)
ATP-binding cassette, sub-family F,
member 3
Electron transfer ﬂavoprotein subunit
beta (Beta-ETF).
Molybdenum cofactor biosynthesis
protein 1B (MOCS1B)
Gephyrin

Human gene name

TABLE IV. Homologous Human Genes among the 119 Genes Deleted by DuvrB in Strain TA98 of Salmonella

Lamellar ichthyosis type 2;
Harlequin ichthyosis

gyrate atrophy

molybdenum cofactor deﬁciency

molybdenum cofactor deﬁciency

methylbutyryl glycinuria

neurological condition hyperplexia,
molybdenum cofactor deﬁciency

molybdenum cofactor deﬁciency

glutaric aciduria II

galactose epimerase deﬁciency
histidinemia

glutaric aciduria II

Disease due to nonfunctional gene

Q9H6P5

EAW70520

Q96SZ6

O94911

P04181

O95396

Q9NZB8

O75600
P45954

Q9NQX3

Q9NZB8

P38117

Q14376
P42357
O00571
Q9NUQ8

Q16134

Human
accession
number

Environmental and Molecular Mutagenesis. DOI 10.1002/em
Enhanced Mutagenesis of Salmonella Tester Strains
703

Environmental and Molecular Mutagenesis. DOI 10.1002/em
704

Swartz et al.

of mutagens. Although there was no knowledge of the
underlying basis for the differential sensitivity of one
strain compared with another, the current tester strains are
a result of this selection process. Our previous [Porwollik
et al., 2001] and current studies identify that the deletion
of some genes accounts for the sensitivity of the selected
strains.
The standard ﬁve Ames strains (TA97, TA98, TA100,
TA104, and TA1537) are missing genes associated with
molybdenum cofactor biosynthesis, moaABCDE [Porwollik et al., 2001]. Molybdoenzymes inactivate Nhydroxyl compounds (hydroxylamines), which are active
intermediates for the mutagenic activity of both aromatic
nitro-compounds and aromatic amines [Rosenkranz et al.,
1983]. This helps explain the ﬁnding that mutagens in
these chemical classes are among those that exhibit differences in mutagenic potency and speciﬁcity at the basesubstitution or frameshift allele of Salmonella when comparing DuvrB versus uvr1 strains [DeMarini, 2000]. These
mutagens include aromatic amines such as 2-AAF and 4AB, heterocyclic amines such as Glu-P-1, and nitroarenes
such as 1-NP [DeMarini, 2000].
The deletion of many other genes might enhance the
mutagenic potency of various mutagens. For example, the
deletion of dinG (a lexA-regulated gene), rhlE (an RNA
helicase), dps (a stress-response-speciﬁc DNA-binding protein), and yliJ (a glutathione S-transferase) [Porwollik
et al., 2001] may reduce the ability of the D(gal-bio-uvrB)
strains to repair DNA damage or to inactivate mutagens.
The genes mdfA and mdaA (nfsA), which encode, respectively, a multi-drug translocase and a major oxygen-independent nitroreductase, are missing from TA98. The deletion of mdaA (nfsA) is especially important for mutagenesis
considering the long-recognized role of nitroreductases for
the activation of nitroarenes to mutagens [Rosenkranz
et al., 1982]. The deletion of various membrane-transport
genes and genes of unknown function [Porwollik et al.,
2001] may also inﬂuence mutagenic potency.
As noted earlier, the single-gene defects studied here
have a differential effect on mutagenesis at the frameshift
versus the base-substitution allele (Table III). At the frameshift allele, the absence of just the nucleotide excision
repair system along with the molybdenum cofactor synthesis system is generally sufﬁcient to account for the mutagenic potency exhibited by the compounds in TA98
(Table III). Interestingly, the deletion of these two classes
of genes causes 1-NP and MX to be more mutagenic than
they are in TA98. The absence of additional genes among
the 119 genes missing in TA98 beyond uvrB and the molybdenum cofactor synthesis genes probably does not
increase the mutagenic potency of compounds at the frameshift allele but may somewhat decrease their potency.
Moreover, S9 may reintroduce metabolic factors originally removed in the D(gal-bio-uvrB) that are necessary
for full mutagenic activity of many compounds.

In contrast, deletion of these two classes of genes is
insufﬁcient to account for the mutagenic potency of the
compounds at the base-substitution allele in TA100.
Although only 47 genes are missing in TA100 (all of
which are also missing in TA98), some of these deleted
genes in addition to uvrB and the moeA/moaA genes
clearly inﬂuence the mutagenic potencies of compounds
in TA100. Thus, some of the missing genes described earlier exert a signiﬁcant inﬂuence on both spontaneous and
mutagen-induced base-substitution mutagenesis. At the
frameshift allele, some of the additional 72 missing genes
in TA98 (119 – 47 5 72) may compensate or otherwise
cancel out the inﬂuence of the 47 genes missing among
both TA98 and TA100.
Human Homologues of Genes Deleted
in D(gal-bio-uvrB) Strains
Our ﬁnding that the absence of at least molybdenum
cofactor biosynthesis enhances spontaneous and induced
mutagenesis at the base-substitution allele of Salmonella
prompted us to consider the health consequences of mutations in such genes in humans. Among the 17 genes that
emerged from this analysis (Table IV), the most prevalent
cellular function affected by the genes listed in Table IV
is molybdenum cofactor biosynthesis. Human molybdenum cofactor deﬁciency is a rare and devastating autosomal-recessive disease for which no therapy is known. The
absence of active sulﬁte oxidase, which is a molybdenum
cofactor-dependent enzyme, results in neonatal seizures
and early childhood death [Lee et al., 2002]. The loss of
molybdenum cofactor results in a complete inactivation of
the MoCo-dependent enzymes sulﬁte oxidase and xanthine dehydrogenase. This inactivation could lead to
increased sulﬁte levels, which might deplete glutathione.
Depleted glutathione would compromise cellular response
to oxidative stress and could lead to increased levels of
DNA damage [Graf et al., 1998].
The deleted Salmonella genes and their human homologues catalyze reactions that are important for the physiology of any cell. This importance is reﬂected in the conservation of amino acid sequences of these genes from bacteria to humans. The present study and previous work in E.
coli [Kozmin et al., 2000] indicate clearly that deletion of
molybdenum cofactor biosynthesis genes in bacteria enhances susceptibility to mutagenesis by certain base analogues
as well as by a wide range of environmental mutagens.
Our data suggest the possibility that enhanced susceptibility to mutagenesis or elevated spontaneous mutagenesis
may underlay some aspects of the diseases associated with
deﬁciency in molybdenum biosynthesis in humans.
Implications for Mutagenicity Screening
Our results show that the deletion of large numbers of
genes other than uvrB in TA98 and TA100 does not di-
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minish the ability of these strains to identify mutagens or
assess mutagenic potency. In fact, at the base-substitution
allele, all mutagens tested were more mutagenic in TA100
compared to the homologous strain with the single uvrB
defect. Similarly, at the frameshift allele, all mutagens
tested were either equally or more mutagenic in TA98
compared with the homologous strain with a single uvrB
defect. Thus, the D(gal-bio-uvrB) mutation enhances the
mutagenic potency of nearly all compounds tested at both
alleles and permits the detection of the base analogues,
which otherwise would be negative in a strain with the single uvrB defect. Other than the base analogues, all mutagens were mutagenic both in D(gal-bio-uvrB) and uvrB
strains, with the exception of 4-AB in the frameshift uvrB
strain (SN15944), which had a mutagenic potency that was
almost (P 5 0.06) signiﬁcantly different from zero.
Thus, the absence of the genes due to the D(gal-biouvrB) mutation does not cause mutagens to be missed
that would otherwise have been detected in a uvrB strain.
In fact, D(gal-bio-uvrB) actually enhanced the ability to
detect most mutagens, especially at the base-substitution
allele. These ﬁndings demonstrate for the ﬁrst time that
the inclusion of the D(gal-bio-uvrB) mutations into the
Ames tester strains of Salmonella generally enhances the
mutagenic sensitivity of the strains beyond that conferred
by uvrB alone. Given that the means to produce a mutation in only uvrB was not available in the late 1960s
when the strains were ﬁrst developed, it is perhaps fortuitous that a D(gal-bio-uvrB) mutation was used.
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